Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiology of NMOSD in Sweden from 1987 to 2013
Dagur Ingi Jonsson, Ólafur Sveinsson, Ramil Hakim, et al.
Neurology (2019) Vol. 93, Iss. 2
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Neuromyelitis optica
Sven Jarius, Friedemann Paul, Brian G. Weinshenker, et al.
Nature Reviews Disease Primers (2020) Vol. 6, Iss. 1
Closed Access | Times Cited: 338
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
Jyh Yung Hor, Nasrin Asgari, Ichiro Nakashima, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 305
Worldwide Incidence and Prevalence of Neuromyelitis Optica
Viktoria Papp, Melinda Magyari, Orhan Aktaş, et al.
Neurology (2020) Vol. 96, Iss. 2, pp. 59-77
Open Access | Times Cited: 198
Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study
De‐Cai Tian, Zixiao Li, Meng Yuan, et al.
The Lancet Regional Health - Western Pacific (2020) Vol. 2, pp. 100021-100021
Open Access | Times Cited: 55
Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseases
Itay Lotan, Gabriela Romanow, Michael Levy
Multiple Sclerosis and Related Disorders (2021) Vol. 55, pp. 103189-103189
Open Access | Times Cited: 42
Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis
Sara Bagherieh, Alireza Afshari-Safavi, Saeed Vaheb, et al.
Neurological Sciences (2023) Vol. 44, Iss. 6, pp. 1905-1915
Closed Access | Times Cited: 21
A comprehensive review of the advances in neuromyelitis optica spectrum disorder
Pakeeran Siriratnam, Saif Huda, Helmut Butzkueven, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 12, pp. 103465-103465
Open Access | Times Cited: 21
Factors associated with the misdiagnosis of neuromyelitis optica spectrum disorder
Alexander D. Smith, Tatum M. Moog, Katy W. Burgess, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 70, pp. 104498-104498
Closed Access | Times Cited: 19
Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis
Simon Arnett, Sin Hong Chew, Unnah Leitner, et al.
Journal of Neurology (2024) Vol. 271, Iss. 8, pp. 4794-4812
Open Access | Times Cited: 5
Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation
Elham Khalilidehkordi, Laura Clarke, Simon Arnett, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 38
Status of the neuromyelitis optica spectrum disorder in Latin America
Víctor M. Rivera, Fernando Hamuy, Verónica Rivas, et al.
Multiple Sclerosis and Related Disorders (2021) Vol. 53, pp. 103083-103083
Open Access | Times Cited: 32
Mortality of neuromyelitis optica spectrum disorders in a Chinese population
Qin Du, Ziyan Shi, Hongxi Chen, et al.
Annals of Clinical and Translational Neurology (2021) Vol. 8, Iss. 7, pp. 1471-1479
Open Access | Times Cited: 32
Mortality of the Danish Nationwide AQP4 Antibody-Seropositive Neuromyelitis Optica Spectrum Disorder Patient Cohort
Viktoria Papp, Melinda Magyari, Søren Møller, et al.
Neurology (2024) Vol. 102, Iss. 5
Closed Access | Times Cited: 4
The value of CSF diagnostic and prognostic biomarkers in NMOSD and MOGAD in real-life use
Magnus Johnsson, Kristina Eriksson, Igal Rosenstein, et al.
Multiple Sclerosis and Related Disorders (2025), pp. 106302-106302
Open Access
Intravitreal delivery of NMO-IgG causes primary retinal damage in the absence of optic nerve injury
Biyue Chen, Huanfen Zhou, Mingming Sun, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access
Prevalence of neuromyelitis optica spectrum disorder in Belo Horizonte, Southeast Brazil
Marco Aurélio Lana–Peixoto, Natália Cirino Talim, Denison Pedrosa, et al.
Multiple Sclerosis and Related Disorders (2021) Vol. 50, pp. 102807-102807
Closed Access | Times Cited: 25
A national case–control study investigating demographic and environmental factors associated with NMOSD
Dalia Rotstein, Christina Wolfson, Robert Carruthers, et al.
Multiple Sclerosis Journal (2023) Vol. 29, Iss. 4-5, pp. 521-529
Open Access | Times Cited: 10
The Pathological Activation of Microglia Is Modulated by Sexually Dimorphic Pathways
Jennifer L. O’Connor, Jillian C. Nissen
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4739-4739
Open Access | Times Cited: 10
Drug Treatment of Neuromyelitis Optica Spectrum Disorders: Out with the Old, in with the New?
Friederike Held, Ana-Katharina Klein, Achim Berthele
ImmunoTargets and Therapy (2021) Vol. Volume 10, pp. 87-101
Open Access | Times Cited: 22
Triglyceride Level Is an Independent Risk Factor in First-Attacked Neuromyelitis Optica Spectrum Disorders Patients
Kaimin Wu, Lulu Wen, Ranran Duan, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 21
Evaluating the Economic Burden of Relapses in Neuromyelitis Optica Spectrum Disorder: A Real-World Analysis Using German Claims Data
Rachel Knapp, F. Hardtstock, Thomas Wilke, et al.
Neurology and Therapy (2021) Vol. 11, Iss. 1, pp. 247-263
Open Access | Times Cited: 17
Characterizing mortality in patients with AQP4‐Ab+ neuromyelitis optica spectrum disorder
Anna Francis, Emily Gibbons, Jeffrey Yu, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 7, pp. 1942-1947
Open Access | Times Cited: 2
Questioning the existence of monophasic neuromyelitis optica spectrum disorder by defining a novel long-term relapse-free form from a large Chinese population
Weihe Zhang, Lei Cui, Yeqiong Zhang, et al.
Journal of Neurology (2020) Vol. 267, Iss. 4, pp. 1197-1205
Closed Access | Times Cited: 18
Incidence of neuromyelitis optica spectrum disorders in China: a large cohort study using claim data
Yiqun Wu, Mo Yang, Pei Gao, et al.
BMJ Open (2022) Vol. 12, Iss. 1, pp. e048942-e048942
Open Access | Times Cited: 11
Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry
Edgar Carnero Contentti, Pablo A. López, Juan Pablo Pettinicchi, et al.
Multiple Sclerosis Journal - Experimental Translational and Clinical (2023) Vol. 9, Iss. 4
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top